Company Description
OmniAb (NASDAQ: OABIW) is a publicly traded company in the Services-commercial Physical & Biological Research sector.
OABIW stock has declined 78.6% over the past year. Shares last traded at $0.0800.
On a trailing twelve-month basis, OmniAb reported revenue of $18.7M with net income of -$64.8M and diluted earnings per share of $-0.57. The company operates at a net profit margin of -347.0%.
This page provides a comprehensive overview of OABIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
OmniAb (OABIW) stock last traded at $0.0800. Over the past 12 months, the stock has lost 78.6%.
Latest News
SEC Filings
OmniAb has filed 5 recent SEC filings, including 3 Form 4, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on March 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OABIW SEC filings →
Financial Highlights
OmniAb generated $18.7M in revenue over the trailing twelve months, operating income reached -$69.0M (-369.5% operating margin), and net income was -$64.8M, reflecting a -347.0% net profit margin. Diluted earnings per share stood at $-0.57. The company generated -$36.5M in operating cash flow. With a current ratio of 4.02, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in OmniAb (OABIW) currently stands at 17.4 thousand shares. Over the past 12 months, short interest has increased by 29.5%. With 14.5 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for OmniAb (OABIW) currently stands at 14.5 days, down 59.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 131.7% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 570.5 days.
OABIW Company Profile & Sector Positioning
OmniAb (OABIW) operates in the Services-commercial Physical & Biological Research sector and is listed on the NASDAQ.